SPECIAL NOTICE

We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

InvestoGain Australia

SEARCH BY NAME

BROWSE

Browse Australian listed companies0-9A BC DE FGH IJ KL MN OP QR ST UV WX YZ
Browse current Australian managed funds0-9A BCDE FGH IJKL MNOP QRST UVWX YZ

SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

NOVOGEN LIMITED (NRT)

Listed on ASX ( $0.049    +0.000    +0.000%)

SHARE PRICES

Former (or subsequent) names

 FROMTO
NOVOGEN LIMITED13/05/1997
NORVET LIMITED13/05/1997

Shareholder links

Our website ranking of NRT: rating 4
(4 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Computershare, Level 3, 60 Carrington Street, Sydney NSW 2000

Tel : +61 2 8234 5000
Fax : +61 2 8235 8150
RegistryWebsite RegistryEmail

Company details

Address: Level 5, 20 George St, Hornsby, NSW, 2077
Tel:  + 61 2 9476 0344 Fax: + 61 2 9476 0388

Date first listed: 01/09/1994
Company Secretary: Kate Hill
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Pharmaceutical company involved in the discovery, development, manufacture and marketing of products based on phenolic technology
The suspension of trading in the securities of Novogen Limited (the "Company") will be lifted immediately, following the Company's announcement in relation to the completion of a capital raising. Security Code: NRT12/11/2014
the Closing Date of its current capital raising using the ASX BookBuild Facility has been extended from today Friday 7 November 2014 at 3 pm, to next Tuesday 11 November 2014 07/11/2014
has received confirmation that its experimental drug product, Cantrixil, has passed its final pre-clinical test of efficacy as evidence of its potential to significantly improve the survival prospects of patients with late-stage ovarian cancer06/11/2014
The securities of Novogen Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement in relation to a placement. Security Code: NRT05/11/2014
we understand that on or about this date the company made an in specie distribution of 3 shares in MEI Pharma, Inc for every 40 shares in the company27/11/2012
name changed from Norvet Limited13/05/1997

ASX Announcements (courtesy of ASX)

 

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    Posting your comments. Please wait...


    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    14/06/2017Iain Ross1,000,000 $0.055$55,005
    13/06/2017James Garner125,000 $0.057$7,125
    13/06/2017Steven Coffey320,000 $0.057$18,240
    24/02/2017Steven Coffey100,000 $0.086$8,550
    23/02/2017Iain Ross200,000 $0.090$18,000

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Iain RossNon Exec Chairman22/07/2015
    Mark HinzeCFO18/06/2010
    Steven CoffeyNon Exec Director08/11/2012
    Bryce CarmineNon Exec Director03/06/2015
    James GarnerExecutive Director, CEO01/02/2016

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    John O'ConnorNon Exec Chairman25/05/201208/06/2017
    Ian PhillipsNon Exec Director03/06/201508/06/2017
    Peter GunningNon Exec Director04/03/201405/09/2016
    Graham KellyExecutive Director, CEO07/12/201222/07/2015
    Robert BirchDeputy Chairman, Non Exec Director12/12/201204/03/2014
    Andrew HeatonExecutive Director07/12/201204/03/2014
    Josiah AustinNon Exec Director20/09/201019/04/2013
    William RueckertChairman23/03/200907/12/2012
    Peter WhiteNon Exec Director20/09/201007/12/2012
    Ross YoungmanNon Exec Director20/09/201008/11/2012
    Peter ScuttNon Exec Director29/10/201025/05/2012
    Geoffrey LeppinusNon Exec Director24/02/200529/10/2010
    Philip JohnstonNon Exec Chairman01/01/199718/10/2010
    Christopher NaughtonManaging Director, CEO01/03/199701/12/2009

    Date of first appointment, title may have changed.